5-(saenta-x8)fluorescein has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biggs, JC; Cebon, JS; Gibson, J; Jamieson, GP; McKendrick, JJ; Sheridan, WP; Snook, MB; Szer, J; Wiley, JS; Woodruff, RK | 1 |
| Belch, AR; Chlumecky, V; Gati, WP; Larratt, LM; Mant, MJ; Paterson, AR; Turner, AR | 1 |
1 review(s) available for 5-(saenta-x8)fluorescein and Acute Disease
| Article | Year |
|---|---|
Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC).
Topics: Acute Disease; Antimetabolites, Antineoplastic; Carrier Proteins; Cytarabine; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Gene Expression; Humans; Leukemia, Myeloid, Acute; Lymphocytes; Membrane Proteins; Microscopy, Confocal; Nucleoside Transport Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purine Nucleosides | 1998 |
1 trial(s) available for 5-(saenta-x8)fluorescein and Acute Disease
| Article | Year |
|---|---|
Assessment of proliferative responses to granulocyte-macrophage colony-stimulating factor (GM-CSF) in acute myeloid leukaemia using a fluorescent ligand for the nucleoside transporter.
Topics: Acute Disease; Blood Proteins; Bone Marrow; Bone Marrow Cells; Carrier Proteins; Cell Division; Fluoresceins; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Membrane Proteins; Nucleoside Transport Proteins; Purine Nucleosides; Thymidine; Tritium | 1994 |